Thus, the reduction of the expression level of TIMP3 and SOX1 compared to normal tissue was present both in the TCGA analysis and in the patients enrolled in the validation study, in the CC and CIN group. The gene discussed is SOX1; the disease is cervical squamous intraepithelial neoplasia.